Literature DB >> 28472828

MicroRNA-524-5p Functions as a Tumor Suppressor in a Human Pituitary Tumor-Derived Cell Line.

Wang Zhen1,2, Du Qiu1,2, Chen Zhiyong3, Wang Xin1,2, Jian Mengyao1,2, Zhu Dimin3, Hu Chonghui1,2, Wang Haijun3, Zhu Yonghong1,2.   

Abstract

Clinical nonfunctional pituitary adenomas (NFAs) account for about 40% of pituitary adenomas with almost no clinically relevant hormonal symptoms. Increasing evidence shows that many microRNAs are involved in the development and progression of pituitary adenomas. MicroRNA-524-5p (miR-524-5p) has been reported to cause characteristic alterations in various tumors. However, the functional importance of miR-524-5p in NFAs remains unknown. The aim of this study was to explore the effects of overexpressing miR-524-5p on the proliferation, migration, invasion, and tumorigenicity of pituitary-derived folliculostellate (PDFS) cells using lentiviral transfection. Interestingly, the results showed that overexpressing miR-524-5p downregulated pituitary tumor-transforming gene 1 (PTTG1) binding factor (PBF) expression at both mRNA and protein levels and significantly attenuated cell proliferation, clonogenicity, migration, and invasion in vitro. Moreover, enhancing miR-524-5p blocked tumor growth in a nude mouse xenograft model in vivo. These findings suggest that miR-524-5p appears to play a critical role in the regulation of biological properties of PDFS cells, and may represent a potential therapeutic target for NFAs. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28472828     DOI: 10.1055/s-0043-106437

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  10 in total

Review 1.  Aggressive nonfunctioning pituitary neuroendocrine tumors.

Authors:  Sérgio Portovedo; Leonardo Vieira Neto; Christina Maeda Takiya; Leandro Miranda-Alves; Paula Soares; Denise Pires de Carvalho
Journal:  Brain Tumor Pathol       Date:  2022-06-20       Impact factor: 3.154

2.  LncRNA XIST depletion prevents cancer progression in invasive pituitary neuroendocrine tumor by inhibiting bFGF via upregulation of microRNA-424-5p.

Authors:  Kai Zhou; Shaoshan Li; Guojia Du; Yandong Fan; Pengfei Wu; Hongjie Sun; Tingrong Zhang
Journal:  Onco Targets Ther       Date:  2019-09-02       Impact factor: 4.147

3.  MicroRNA-524-5p suppresses the progression of papillary thyroid carcinoma cells via targeting on FOXE1 and ITGA3 in cell autophagy and cycling pathways.

Authors:  Hui Liu; Xi Chen; Ting Lin; Xingsheng Chen; Jiqi Yan; Shan Jiang
Journal:  J Cell Physiol       Date:  2019-04-02       Impact factor: 6.384

4.  LncRNA MSC-AS1 aggravates nasopharyngeal carcinoma progression by targeting miR-524-5p/nuclear receptor subfamily 4 group A member 2 (NR4A2).

Authors:  Hongchao Yao; Like Yang; Linli Tian; Yan Guo; Yushan Li
Journal:  Cancer Cell Int       Date:  2020-04-28       Impact factor: 5.722

Review 5.  Multiple Endocrine Neoplasia Type 1: The Potential Role of microRNAs in the Management of the Syndrome.

Authors:  Simone Donati; Simone Ciuffi; Francesca Marini; Gaia Palmini; Francesca Miglietta; Cinzia Aurilia; Maria Luisa Brandi
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

Review 6.  Genetic and Epigenetic Causes of Pituitary Adenomas.

Authors:  Mengqi Chang; Chengxian Yang; Xinjie Bao; Renzhi Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-26       Impact factor: 5.555

Review 7.  The Emerging Role of Non-Coding RNAs in Pituitary Gland Tumors and Meningioma.

Authors:  Soudeh Ghafouri-Fard; Atefe Abak; Bashdar Mahmud Hussen; Mohammad Taheri; Guive Sharifi
Journal:  Cancers (Basel)       Date:  2021-11-28       Impact factor: 6.639

8.  LncRNA TTN-AS1 Regulates miR-524-5p and RRM2 to Promote Breast Cancer Progression.

Authors:  Hui Feng; Qi Wang; Wenjing Xiao; Biyuan Zhang; Yonglong Jin; Haijun Lu
Journal:  Onco Targets Ther       Date:  2020-05-27       Impact factor: 4.147

Review 9.  MiRNAs as Noninvasive Biomarkers and Therapeutic Agents of Pituitary Adenomas.

Authors:  Ozal Beylerli; Narasimha M Beeraka; Ilgiz Gareev; Valentin Pavlov; Guang Yang; Yanchao Liang; Gjumrakch Aliev
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

Review 10.  Novel Insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms.

Authors:  Vinaya Srirangam Nadhamuni; Márta Korbonits
Journal:  Endocr Rev       Date:  2020-12-01       Impact factor: 19.871

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.